Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial
Conjugate
DOI:
10.1186/s12951-015-0072-x
Publication Date:
2015-02-02T13:39:03Z
AUTHORS (11)
ABSTRACT
Cancer metastasis caused by circulating tumor cells (CTCs) accounts for 90% cancer-related death worldwide. Blocking the circulation of CTCs in bloodstream and their hetero-adhesion to vascular endothelia distant metastatic organs may prevent cancer metastasis. Nanomaterial-based intervention with adhesion between has not been reported. Driven novel idea that multivalent conjugation EpCAM Slex antibodies dendrimer surface enhance capacity specificity nanomaterial conjugates capturing down-regulating colorectal CTCs, we conjugated antibodies, examined dual antibody-coated roles interrupting CTCs-related The was synthesized characterized. specifically bound captured colon SW620. conjugate inhibited cells' viability fibronectin (Fn)-coated substrate or human umbilical vein endothelial (HUVECs) a concentration-dependent manner. In comparison SW480 LoVo cell lines, activity SW620 Fn-coated HUVECs were more antibody because higher levels on surface. substrate, about 60-70%. showed inhibition significant than its corresponding single conjugates. present study provides new evidence coating nanomaterials one against effectively interfere interaction HUVECs.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (14)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....